|
1
|
Nieschlag E, Swerdloff R, Behre HM, Gooren
LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang
C, et al: Investigation, treatment, and monitoring of late-onset
hypogonadism in males: ISA, ISSAM, and EAU recommendations. J
Androl. 27:135–137. 2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Feldman HA, Longcope C, Derby CA, Johannes
CB, Araujo AB, Coviello AD, Bremner WJ and McKinlay JB: Age trends
in the level of serum testosterone and other hormones in
middle-aged men: Longitudinal results from the Massachusetts male
aging study. J Clin Endocrinol Metab. 87:589–598. 2002.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wu FC, Tajar A, Pye SR, Silman AJ, Finn
JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, et
al: Hypothalamic-pituitary-testicular axis disruptions in older men
are differentially linked to age and modi able risk factors: The
European Male Aging Study. J Clin Endocrinol Metab. 93:2737–2745.
2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang C, Nieschlag E, Swerdloff R, Behre
HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B,
Morales A, et al: Investigation, treatment and monitoring of
late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA
recommendations. Eur J Endocrinol. 159:507–514. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Japanese Urological Association/Japanese
Men's Health Medicine Association: LOH symptom group - Aging Male
Hypogonadism Syndrome Medical Guidance. Jihou, Tokyo, 4-7,
2007.
|
|
6
|
Okamura K, Ando F and Shimokata H: Serum
total and free testosterone level of Japanese men: A
population-based study. Int J Urol. 12:810–814. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Iwamoto T, Yanase T, Horie H, Namiki M and
Okuyama A: Late-onset hypogonadism (LOH) and androgens: Validity of
the measurement of free testosterone levels in the diagnostic
criteria in Japan. Int J Urol. 16:168–174. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Miwa Y, Kaneda T and Yokoyama O:
Correlation between the Aging Males' symptoms Scale and sex
steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth
hormone levels in ambulatory men. J Sex Med. 3:723–726.
2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nieschlag E: Testosterone treatment comes
of age: New options for hypogonadal men. Clin Endocrinol (Oxf).
65:275–281. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang C, Swerdloff RS, Iranmanesh A, Dobs
A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T and Berman N:
Testosterone Gel Study Group. Transdermal testosteron gel improves
sexual function, mood, muscle strength, body composition parameters
in hypogonadal men. J Clin Endocrinol Metab. 85:2839–2853.
2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tenover JS: Effects of testosterone
supplementation in the aging male. J Clin Endocrinol Metab.
75:1092–1098. 1992.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Buvat J, Maggi M, Gooren L, Guay AT,
Kaufman J, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A
and Zitzmann M: Endocrine aspects of male sexual dysfunctions. J
Sex Med. 7:1627–1656. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ide H, Yasuda M, Nishio K, Saito K,
Isotani S, Kamiyama Y, Muto S and Horie S: Development of a
nomogram for predicting high-grade prostate cancer on biopsy: The
significance of serum testosterone levels. Anticancer Res.
28C:2487–2492. 2008.PubMed/NCBI
|
|
14
|
Bagatell CJ and Bremner WJ: Androgens in
men: Uses and abuses. N Engl J Med. 334:707–714. 1996.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Coates JM and Herbert J: Endogenous
steroids and financial risk taking on a London trading floor. Proc
Natl Acad Sci USA. 105:6167–6172. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Muller M, Grobbee DE, den Tonkelaar I,
Lamberts SW and van der Schouw YT: Endogenous sex hormones and
metabolic syndrome in aging men. J Clin Endocrinol Metab.
90:2618–2623. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bhasin S, Cunningham GR, Hayes FJ,
Matsumoto AM, Snyder PJ, Swerdloff RS and Montori VM: Testosterone
therapy in adult men with androgen deficiency syndromes: An
endocrine society clinical practice guideline. J Clin Endocrinol
Metab. 91:1995–2010. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Srinivas-Shankar U, Roberts SA, Connolly
MJ, O'Connell MD, Adams JE, Oldham JA and Wu FC: Effects of
testosterone on muscle strength, physical function, body
composition, and quality of life in intermediate-frail and frail
elderly men: A randomized, double-blind, placebo-controlled study.
J Clin Endocrinol Metab. 95:639–650. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Amano T, Imao T and Takemae K: Clinical
efficacy of Japanese traditional herbal medicine (Kampo) in
patients with late-onset hypogonadism. Aging Male. 13:166–173.
2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tsujimura A, Takada S, Matsuoka Y,
Nakayama J, Takao T, Miyagawa Y, Nonomura N and Okuyama A: Clinical
trial of treatment with saikokaryukotsuboreito for eugonadal
patients with late-inset hypogonadism-related symptoms. Aging Male.
11:95–99. 2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Takeuchi H, Taoka R, Mmeje CO, Jinesh GG,
Safe S and Kamat AM: CDODA-Me decreases specificity protein
transcription factors and induces apoptosis in bladder cancer cells
through induction of reactive oxygen species. Urol Oncol.
34:337.e11–8. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yasuda M, Ide H and Horie S, Yoshii T,
Nishio K, Saito K, Isotani S, Kamiyama Y, Muto S and Horie S:
Salivary 8-OHdG: A useful biomarker for predicting severe ED and
hypogonadism. J Sex Med. 5:1482–1491. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Podlasek CA, Mulhall J, Davies K, Wingard
CJ, Hannan JL, Bivalacqua TJ, Musicki B, Khera M, González-Cadavid
NF and Burnett AL II: Translational perspective on the role of
testosterone in sexual function and dysfunction. J Sex Med.
13:1183–1198. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Amano T, Iwamoto T, Sato Y, Imao T and
Earle C: The efficacy and safety of short-acting testosterone
ointment (Glowmin) for late-onset hypogonadism in accordance with
testosterone circadian rhythm. Aging Male. 21:170–175.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Heinemann LA, Zimmermann T, Vermeulen A,
Thiel C and Hummel W: A new ‘aging males’ symptoms' (AMS) rating
scale. Aging Male. 2:105–114. 1999.
|
|
26
|
Barry MJ, Fowler FJ Jr, O'Leary MP,
Bruskewitz RC, Holtgrewe HL, Mebust WK and Cockett AT: The American
urological association symptom index for benign prostatic
hyperplasia. The measurement committee of the American urological
association. J Urol. 148:1549–1557; discussion 1564.
1992.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rosen RC, Cappelleri JC, Smith MD, Lipsky
J and Peña BM: Development and evaluation of an abridged, 5-item
version of the International index of erectile function (IIEF-5) as
a diagnostic tool for erectile dysfunction. Int J Impot Res.
11:319–326. 1999.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Frankenfield DC, Rowe WA, Cooney RN, Smith
JS and Becker D: Limits of body mass index to detect obesity and
predict body composition. Nutrition. 17:26–30. 2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
WHO Expert Consultation. Appropriate
body-mass index for Asian populations and its implications for
policy and intervention strategies. Lancet. 363:157–163.
2004.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sato Y, Tanda H, Kato S, Onishi S,
Nakajima H, Nanbu A, Nitta T, Koroku M, Akagashi K and Hanzawa T:
Prevalence of major depressive disorder in self-referred patients
in a late onset hypogonadism clinic. Int J Impot Res. 19:407–410.
2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Takeuchi H, Mmeje CO, Jinesh GG, Taoka R
and Kamat AM: Sequential gemcitabine and tamoxifen treatment
enhances apoptosis and blocks transformation in bladder cancer
cells. Oncol Rep. 34:2738–2744. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Liu CC, Lee YC, Wang CJ, Yeh HC, Li WM, Wu
WJ, Huang CN, Bao BY, Huang CH and Huang SP: The impact of androgen
receptor CAG repeat polymorphism on andropausal symptoms in
different serum testosterone levels. J Sex Med. 9:2429–2437.
2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Coviello AD, Lakshman K, Mazer NA and
Bhasin S: Differences in the apparent metabolic clearance rate of
testosterone in young and older men with gonadotropin suppression
receiving graded doses of testosterone. J Clin Endocrinol Metab.
91:4669–4675. 2006.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wu FC, Tajar A, Beynon JM, Pye SR, Silman
AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva FF, Forti G, et al:
Identification of late-onset hypogonadism in middle-aged and
elderly men. N Engl J Med. 363:123–135. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tsujimura A, Matsumiya K, Matsuoka Y,
Takahashi T, Koga M, Iwasa A, Takeyama M and Okuyama A:
Bioavailable testosterone with age and erectile dysfunction. J
Urol. 170:2345–2347. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cunningham GR, Stephens-Shields AJ, Rosen
RC, Wang C, Ellenberg SS, Matsumoto AM, Bhasin S, Molitch ME,
Farrar JT, Cella D, et al: Association of sex hormones with sexual
function, vitality, and physical function of symptomatic older men
with low testosterone levels at baseline in the testosterone
trials. J Clin Endocrinol Metab. 100:1146–1155. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Holm AC, Fredrikson MG, Theodorsson E,
Palmefors LG, Karlsson PS, Joborn C and Hammar ML: Change in
testosterone concentrations over time is a better predictor than
the actual concentrations for symptoms of late onset hypogonadism.
Aging Male. 14:249–256. 2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zitzmann M, Faber S and Nieschlag E:
Association of specific symptoms and metabolic risks with serum
testosterone in older men. J Clin Endocrinol Metab. 91:4335–4343.
2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Takeuchi H, Ohori M and Tachibana M:
Clinical significance of the prostate-specific antigen doubling
time prior to and following radical prostatectomy to predict the
outcome of prostate cancer. Mol Clin Oncol. 6:249–254.
2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Rastrelli G, Corona G, Vignozzi L,
Maseroli E, Silverii A, Monami M, Mannucci E, Forti G and Maggi M:
Serum PSA as a predictor of testosterone deficiency. J Sex Med.
10:2518–2528. 2013.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Snyder PJ, Bhasin S, Cunningham GR,
Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM,
Barrett-Connor E, Swerdloff RS, Wang C, et al: Effects of
testosterone treatment in older men. N Engl J Med. 374:611–624.
2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Anderson JL, May HT, Lappé DL, Bair T, Le
V, Carlquist JF and Muhlestein JB: Impact of testosterone
replacement therapy on myocardial infarction, stroke, and death in
men with low testosterone concentrations in an integrated health
care system. Am J Cardiol. 117:794–799. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Feneley MR and Carruthers M: Is
testosterone treatment good for the prostate? Study of safety
during long-term treatment. J Sex Med. 9:2138–2149. 2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Morales A and Lunenfeld B: International
Society for the Study of the Aging Male. Investigation, treatment
and monitoring of late-onset hypogonadism in males. Official
recommendations of ISSAM. International Society for the Study of
the Aging Male. Aging Male. 5:74–86. 2002.PubMed/NCBI
|
|
45
|
Rhoden EL and Morgentaler A: Risks of
testosterone-replacement therapy and recommendations for
monitoring. N Engl J Med. 350:482–492. 2004.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gregory SJ and Kaiser UB: Regulation of
gonadotropins by inhibin and activin. Semin Reprod Med. 22:253–267.
2004.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Tsujimura A, Takada S, Matsuoka Y, Hirai
T, Takao T, Miyagawa Y, Nonomura N and Okuyama A: Is
discontinuation of hormone replacement therapy possible for
patients with late-onset hypogonadism? Int J Urol. 15:625–629.
2008.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Khera M, Adaikan G, Buvat J, Carrier S,
El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A,
Torres LO and Salonia A: Diagnosis and treatment of testosterone
deficiency: Recommendations from the Fourth International
consultation for sexual medicine (ICSM 2015). J Sex Med.
13:1787–1804. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Tsujimura A, Miyagawa Y, Okuda H, Yamamoto
K, Fukuhara S, Nakayama J, Takao T, Nonomura N and Okuyama A:
Change in cytokine levels after administration of
saikokaryuukotsuboreito or testosterone in patients with symptoms
of late-onset hypogonadism. Aging Male. 14:76–81. 2011.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Kupelian V, McVary KT, Kaplan SA, Hall SA,
Link CL, Aiyer LP, Mollon P, Tamimi N, Rosen RC and McKinlay JB:
Association of lower urinary tract symptoms and the metabolic
syndrome: Results from the Boston Area Community Health Survey. J
Urol. 182:616–625. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Takeuchi H and Aoyagi T: Clinical
characteristics in urolithiasis formation according to body mass
index. Biomed Rep. 11:38–42. 2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Brand JS, van der Tweel I, Grobbee DE,
Emmelot-Vonk MH and van der Schouw YT: Testosterone, sex
hormone-binding globulin and the metabolic syndrome: A systematic
review and meta-analysis of observational studies. Int J Epidemiol.
40:189–207. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Tsujimura A, Miyagawa Y, Takezawa K, Okuda
H, Fukuhara S, Kiuchi H, Takao T, Yamamoto R, Nishida M,
Yamauchi-Takihara K, et al: Is low testosterone concentration a
risk factor for metabolic syndrome in healthy middle-aged men?
Urology. 82:814–819. 2013.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Corona G, Monami M, Rastrelli G, Aversa A,
Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E and Maggi M:
Testosterone and metabolic syndrome: A meta-analysis study. J Sex
Med. 8:272–283. 2011.PubMed/NCBI View Article : Google Scholar
|
